The HemOnc Pulse
Dr. Venugopal Offers Her Thoughts on the Latest MDS News
Sangeetha Venugopal, MD, of the University of Miami Sylvester Comprehensive Cancer Center, offers her thoughts on the investigational drug KER-050 in lower-risk myelodysplastic syndromes (MDS), the CO